NCT00082121View on ClinicalTrials.gov

Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

December 31, 2005

Conditions
Myocardial IschemiaCoronary ArteriosclerosisAortic Valve InsufficiencyMitral Valve Insufficiency
Interventions
DRUG

TP10

Trial Locations (18)

20010

Washington D.C.

21204

Towson

24541

Danville

30342

Atlanta

32610

Gainesville

32803

Orlando

34239

Sarasota

38120

Memphis

45219

Cincinnati

48202

Detroit

48910

Lansing

53215

Milwaukee

53792

Madison

60612

Chicago

77030

Houston

94115

San Francisco

02118

Boston

01199

Springfield

Sponsors
All Listed Sponsors
lead

Avant Immunotherapeutics

INDUSTRY